Skip to main content

Advertisement

Table 1 Inclusion/exclusion criteria used for recruitment of patients in the study

From: Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancroftiin asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study

Inclusion criteria Exclusion criteria
   a) Apparently healthy individuals with normal body weight for age    a) Haemoglobin < 10 gm/dl or Haematocrit < 30%
   b) W. bancrofti microfilaraemia (in one millilitre of venous blood collected between 8.30 and 9.30 p.m.)    b) Symptoms/signs of any chronic illness
   c) Normal electro-cardiogram (ECG)    c) Patients with a history of any drug intolerance, reaction or allergy
   d) Normal chest X-ray    d) Presence of cysts or ova of intestinal helminths by routine stool examination
   e) Results within normal limits in routine stool and urine examination    e) Patients giving history of consuming either albendazole or DEC in the preceding year
   f) Results within normal limits for haemoglobin concentration, total white blood cell count, differential count, absolute eosinophil count, erythrocyte sedimentation rate, packed cell volume    f) Declared unfit by physician for any other reason.
   g) Results within normal limits for blood urea, glucose, bilirubin, creatinine, cholesterol; serum sodium, potassium, chloride, protein, albumin, globulin, serum glutamic pyruvic transaminase, alkaline phosphatase